🔎 Trials Near Me

Home › NCT05657964

Randomized Trial for cLBP (Gokhale Project)

RecruitingObservational study

A Randomized Comparative Effectiveness Trial of Two Postural Therapies for People With Chronic Lower Back Pain (cLBP)-Gokhale Project

Who can join

Ages 18 to 65 · All sexes

Full eligibility criteria
Inclusion Criteria:

* 18-65 years old (working age population).
* NPRS score 4 or more for lower back.
* RMDQ score 7 and above.
* English speaking population
* Need insurance

Exclusion Criteria:

* Pregnancy (as stated by patient)
* With cognitive or communication impairment .
* Patients recommended for surgery
* Participating in other form of intervention.
* Prior history of chronic neurological disorder that impacts mobility (e.g. stroke, Parkinson's disease, multiple sclerosis)
* Fibromyalgia
* Underwent PT treatment for low back pain in the last 6 months
* Underlying mental disorder/untreated depression or presence of neurologic disorders such as MS, Alzheimers, Parkinsons

About the study

The study aims to compare the effectiveness of the Gokhale Method posture therapy for low back pain (LBP) management to standard physical therapy (PT) with posture training. The second aim of this study is to evaluate usability and user adherence of the online/digital intervention through the Gokhale Method Foundation Class (online delivery with smartphone App).

The investigator hopes to learn:

The effectiveness of the Gokhale Method posture therapy for low back pain management, in comparison to the effectiveness of standard physical therapy with posture training.

the usability and user adherence of the online/digital intervention through the Gokhale Method Foundation Class (online delivery with smartphone App).

What is being tested

Sponsor: Stanford University · Participants: 100 · Started: Jul 1, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT05657964

Locations in the U.S.

CaliforniaOutpatient Surgery Center/Stanford Spine Clinic, Redwood City

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.